A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

(S,R)-Labetalol | CAS 83167-32-2 - Request Quote

Picture of (S,R)-Labetalol

(S,R)-Labetalol

SZ CAT No:SZ-L007033
CAS No
83167-32-2
Mol.F.
C19H24N2O3
Mol.Wt.
328.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

(S,R)-Labetalol is chemically 2-Hydroxy-5-((S)-1-hydroxy-2-(((R)-4-phenylbutan-2-yl)amino)ethyl)benzamide. (S,R)-Labetalol is supplied with detailed characterization data compliant with regulatory guideline. (S,R)-Labetalol can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Labetalol.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 83167-32-2

Purchase 83167-32-2

Order 83167-32-2

Enquire 83167-32-2

price of 83167-32-2

83167-32-2 Supplier

83167-32-2 Manufacturer

83167-32-2 Exporter

buy high quality (S,R)-Labetalol

Purchase (S,R)-Labetalol

(S,R)-Labetalol suppliers

(S,R)-Labetalol manufacturers

(S,R)-Labetalol price

Order (S,R)-Labetalol

Enquire (S,R)-Labetalol

(S,R)-Labetalol cost

(S,R)-Labetalol Supplier

(S,R)-Labetalol Distributor

(S,R)-Labetalol for Method Validation

Labetalol Reference Standard

(S,R)-Labetalol for ANDA Filing

(S,R)-Labetalol for Forced Degradation Studies

(S,R)-Labetalol Identification Standards

(S,R)-Labetalol for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,